1 / 4

Michael Shmilovich, Esq, CLP Technology Licensing Specialist Office of Technology Transfer National Institutes of Health

Michael Shmilovich, Esq, CLP Technology Licensing Specialist Office of Technology Transfer National Institutes of Health U.S. Department of Health & Human Services. FLC Mid-Atlantic Regional Rocky Gap Resort, Flintstone, MD. September 17, 2008. CRADA and Licensing Timeline.

damali
Download Presentation

Michael Shmilovich, Esq, CLP Technology Licensing Specialist Office of Technology Transfer National Institutes of Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Michael Shmilovich, Esq, CLP Technology Licensing Specialist Office of Technology Transfer National Institutes of Health U.S. Department of Health & Human Services FLC Mid-Atlantic Regional Rocky Gap Resort, Flintstone, MD September 17, 2008

  2. CRADA and Licensing Timeline May 2003 – Dr. Knight begins work as a special volunteer at Dr. Ito’s lab November 2003 -- Washington Biotechnology buys Peptide Tech April 9, 2007 – CRADA expires April 9, 2003 – Peptide Tech executes CRADA May 9, 2006 – Amendment to CRADA change of name to CC Biotech Sept 30, 2004 – National Phase entry U.S. only April 5, 2002 – Prov App background rights March 25, 2003 – PCT application on background rights Dec 27, 2007 – Prov App improvement

  3. NIH assumed risk Dr. Knight special volunteer; continues work CRADA collaborator name swap Exclusive license Patent on improvements? Foreign patent apps for background rights dropped Long lag time between CRADA re-start Special volunteer = rights assigned to U.S. Gov’t Patent costs = EXPEN$IVE Lessons Learned

  4. Michael Shmilovich, JD, CLP mish@codon.nih.gov (301) 435-5019

More Related